| 14th Oct 2021 7:01 am |
RNS |
Appointment of Joint Corporate Broker |
| 14th Oct 2021 7:00 am |
RNS |
Agreement signed with ExCEEd Orphan for CEE |
| 11th Oct 2021 7:00 am |
RNS |
Phase 1 data for DITEST published in EJE |
| 8th Oct 2021 12:24 pm |
RNS |
Exercise of Options, Issue of Equity and TVR |
| 7th Oct 2021 11:15 am |
EQS |
Hardman & Co Research | Diurnal (DNL) Life Sciences Investor Forum |
| 6th Oct 2021 3:53 pm |
RNS |
Posting of Annual Report and Notice of AGM |
| 30th Sep 2021 12:08 pm |
RNS |
Holding(s) in Company |
| 29th Sep 2021 2:35 pm |
RNS |
Holding(s) in Company |
| 17th Sep 2021 7:00 am |
RNS |
Hardman & Co Life Sciences Investor Forum |
| 16th Sep 2021 10:15 am |
EQS |
Hardman & Co Research: Diurnal Group (DNL): All set for three pivotal trials |
| 15th Sep 2021 9:17 am |
RNS |
Director Dealings |
| 14th Sep 2021 7:00 am |
RNS |
Results for the year ended 30 June 2021 |
| 13th Sep 2021 7:00 am |
RNS |
Commercial launch of Efmody in the UK |
| 1st Sep 2021 7:00 am |
RNS |
Diurnal launches Efmody in Germany and Austria |
| 19th Aug 2021 7:00 am |
RNS |
Full Year Results Investor Presentation |
| 12th Aug 2021 7:20 am |
EQS |
Hardman & Co Video Event | Diurnal Group plc - Investor Forum |
| 2nd Aug 2021 7:00 am |
RNS |
Grant of Deferred Share Awards |
| 28th Jul 2021 7:00 am |
RNS |
Business and Trading Update |
| 14th Jul 2021 7:00 am |
RNS |
Director Dealings |
| 12th Jul 2021 7:00 am |
RNS |
Agreement from US FDA on SPA for Chronocort |
| 9th Jul 2021 8:30 am |
RNS |
Director Dealings and Issue of Equity |
| 7th Jul 2021 7:00 am |
RNS |
Notice of Full Year Results |
| 5th Jul 2021 7:00 am |
RNS |
Shares and AJ Bell Investor Evening Webinar |
| 2nd Jul 2021 7:00 am |
RNS |
Marketing Authorisation for Efmody in GB from MHRA |
| 29th Jun 2021 7:00 am |
RNS |
Distribution agreement with Er-Kim |
| 2nd Jun 2021 12:19 pm |
RNS |
Director Dealings |
| 1st Jun 2021 7:00 am |
RNS |
Diurnal triggers milestone payments from Citrine |
| 28th May 2021 2:33 pm |
RNS |
European Commission approval received for Efmody |
| 13th May 2021 7:00 am |
RNS |
Correction: Director Dealings |
| 12th May 2021 5:32 pm |
RNS |
Director Dealings |
| 12th May 2021 3:44 pm |
RNS |
Director Dealings |
| 12th May 2021 1:58 pm |
RNS |
Holding(s) in Company |
| 12th May 2021 12:08 pm |
RNS |
Holding(s) in Company |
| 12th May 2021 7:00 am |
RNS |
Agreement with Citrine Medicine for Efmody |
| 11th May 2021 4:43 pm |
RNS |
Holding(s) in Company |
| 11th May 2021 3:25 pm |
RNS |
Holding(s) in Company |
| 10th May 2021 10:26 am |
RNS |
Result of General Meeting |
| 23rd Apr 2021 7:00 am |
RNS |
Grant of second European Patent for Alkindi |
| 21st Apr 2021 11:51 am |
RNS |
Result of Placing and Subscription |
| 21st Apr 2021 7:00 am |
RNS |
Proposed Placing, Subscription and Open Offer |
